Skip to main content
Top
Published in: Respiratory Research 1/2021

Open Access 01-12-2021 | Sarcoidosis | Research

Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis

Authors: Steven Ronsmans, Jolien De Ridder, Eline Vandebroek, Stephan Keirsbilck, Benoit Nemery, Peter H. M. Hoet, Steven Vanderschueren, Wim A. Wuyts, Jonas Yserbyt

Published in: Respiratory Research | Issue 1/2021

Login to get access

Abstract

Background

Sarcoidosis most commonly affects lungs and intrathoracic lymph nodes, but any other organ can be involved. In epidemiological studies, many occupational and environmental exposures have been linked to sarcoidosis but their relationship with the disease phenotype has barely been studied.

Objective

To investigate how occupational and environmental exposures prior to diagnosis relate to organ involvement in patients with sarcoidosis

Methods

We retrospectively studied patients seen at a sarcoidosis clinic between 2017 and 2020. Patients were included if they had a clinical presentation consistent with sarcoidosis and histologically confirmed epithelioid granulomas or had Löfgren syndrome. In a case–case analysis using multivariable logistic regression we calculated odds ratios (OR) of prespecified exposure categories (based on expert ascertainment) for cases with a given organ involvement versus cases without this organ involvement.

Results

We included 238 sarcoidosis patients. Sarcoidosis limited to pulmonary involvement was associated with exposure to inorganic dust prior to diagnosis (OR 2.11; 95% confidence interval [CI] 1.11–4.17). Patients with liver involvement had higher odds of contact with livestock (OR 3.68; 95% CI 0.91–12.7) or having jobs with close human contact (OR 4.33; 95% CI 1.57–11.3) than patients without liver involvement. Similar associations were found for splenic involvement (livestock: OR 4.94, 95% CI 1.46–16.1; close human contact: OR 3.78; 95% CI 1.47–9.46). Cardiac sarcoidosis was associated with exposure to reactive chemicals (OR 5.08; 95% CI 1.28–19.2) or livestock (OR 9.86; 95% CI 1.95–49.0). Active smokers had more ocular sarcoidosis (OR 3.26; 95% CI 1.33–7.79).

Conclusions

Our study indicates that, in sarcoidosis patients, different exposures might be related to different organ involvements—hereby providing support for the hypothesis that sarcoidosis has more than one cause, each of which may promote a different disease phenotype.
Appendix
Available only for authorised users
Literature
1.
go back to reference Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–67.CrossRef Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–67.CrossRef
2.
go back to reference Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O’Reilly K, Ho L-P, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018; 51. Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O’Reilly K, Ho L-P, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018; 51.
3.
go back to reference Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander JP, Newman LS, Rose C, Magira E, Monos D, ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:125–32.PubMed Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander JP, Newman LS, Rose C, Magira E, Monos D, ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:125–32.PubMed
4.
go back to reference Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Thompson BW, Teirstein AS, Yeager H, Johns CJ, Rabin DL, Rybicki BA, Cherniack R. A case control etiologic study of sarcoidosis. Am J Respir Crit Care Med. 2004;170:1324–30.CrossRef Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Thompson BW, Teirstein AS, Yeager H, Johns CJ, Rabin DL, Rybicki BA, Cherniack R. A case control etiologic study of sarcoidosis. Am J Respir Crit Care Med. 2004;170:1324–30.CrossRef
5.
go back to reference Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, Maliarik MJ, Iannuzzi MC. Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003;123:1527–35.CrossRef Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, Maliarik MJ, Iannuzzi MC. Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003;123:1527–35.CrossRef
6.
go back to reference Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK, Hall C, Kelly KJ, Prezant DJ. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131:1414–23.CrossRef Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK, Hall C, Kelly KJ, Prezant DJ. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131:1414–23.CrossRef
7.
go back to reference Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C, Bresnitz E, Rossman M, Thompson B, Rybicki B, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Teirstein AS, Yeager HJ, Johns CJ, Rabin DL, Cherniack R, Group the AR. Job and industry classifications associated with sarcoidosis in a case–control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med. 2005;47:226.CrossRef Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C, Bresnitz E, Rossman M, Thompson B, Rybicki B, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Teirstein AS, Yeager HJ, Johns CJ, Rabin DL, Cherniack R, Group the AR. Job and industry classifications associated with sarcoidosis in a case–control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med. 2005;47:226.CrossRef
8.
go back to reference Esteves T, Aparicio G, Garcia-Patos V. Is there any association between sarcoidosis and infectious agents? A systematic review and meta-analysis. BMC Pulm Med. 2016;16:165.CrossRef Esteves T, Aparicio G, Garcia-Patos V. Is there any association between sarcoidosis and infectious agents? A systematic review and meta-analysis. BMC Pulm Med. 2016;16:165.CrossRef
9.
go back to reference Newman KL, Newman LS. Occupational causes of sarcoidosis. Curr Opin Allergy Clin Immunol. 2012;12:145–50.CrossRef Newman KL, Newman LS. Occupational causes of sarcoidosis. Curr Opin Allergy Clin Immunol. 2012;12:145–50.CrossRef
10.
go back to reference James WE, Koutroumpakis E, Saha B, Nathani A, Saavedra L, Yucel RM, Judson MA. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 2018;154:349–56.CrossRef James WE, Koutroumpakis E, Saha B, Nathani A, Saavedra L, Yucel RM, Judson MA. Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 2018;154:349–56.CrossRef
11.
go back to reference Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:119–27.PubMed Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:119–27.PubMed
12.
go back to reference Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J, Bresnitz E, Judson MA, Lackland DT, Rossman MD. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest. 2005;128:207–15.CrossRef Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J, Bresnitz E, Judson MA, Lackland DT, Rossman MD. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest. 2005;128:207–15.CrossRef
14.
go back to reference De Ridder J, Ronsmans S, Vanderschueren S, Wuyts W, Yserbyt J. Clinical characteristics of sarcoidosis patients in Belgium. Acta Clin. Belg. 2020. De Ridder J, Ronsmans S, Vanderschueren S, Wuyts W, Yserbyt J. Clinical characteristics of sarcoidosis patients in Belgium. Acta Clin. Belg. 2020.
15.
go back to reference Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and detection of sarcoidosis: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26–51.CrossRef Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and detection of sarcoidosis: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e26–51.CrossRef
16.
go back to reference Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S-I, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li H-P, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TWS. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMed Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S-I, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li H-P, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TWS. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMed
17.
go back to reference Calcagno V, de Mazancourt C. glmulti: an R package for easy automated model selection with (generalized) linear models. J Stat Softw. 2010; 34. Calcagno V, de Mazancourt C. glmulti: an R package for easy automated model selection with (generalized) linear models. J Stat Softw. 2010; 34.
18.
go back to reference Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2710–4.CrossRef Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:2710–4.CrossRef
19.
go back to reference R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2019. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2019.
20.
go back to reference von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P, Vandenbroucke J. The strengthening the reporting of observational studies in epidemiology (STROBE) statement. Epidemiology. 2007;18:800–4.CrossRef von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P, Vandenbroucke J. The strengthening the reporting of observational studies in epidemiology (STROBE) statement. Epidemiology. 2007;18:800–4.CrossRef
21.
go back to reference Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, Schuler CR, Takaro TK, Wambach PF, ATS Ad Hoc Committee on Beryllium Sensitivity and Chronic Beryllium Disease. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014;190:34–59.CrossRef Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, Schuler CR, Takaro TK, Wambach PF, ATS Ad Hoc Committee on Beryllium Sensitivity and Chronic Beryllium Disease. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014;190:34–59.CrossRef
22.
go back to reference Stuart BO. Deposition and clearance of inhaled particles. Environ Health Perspect. 1976;16:41–53.CrossRef Stuart BO. Deposition and clearance of inhaled particles. Environ Health Perspect. 1976;16:41–53.CrossRef
23.
go back to reference Wang C. Inhaled particles. 1st ed. Amsterdam: Elsevier Academic Press; 2005. Wang C. Inhaled particles. 1st ed. Amsterdam: Elsevier Academic Press; 2005.
24.
go back to reference Gehr P, Mühlfeld C, Rothen-Rutishauser B, Blank F, eds. Particle-Lung Interactions. 2nd edition. CRC Press; 2009. Gehr P, Mühlfeld C, Rothen-Rutishauser B, Blank F, eds. Particle-Lung Interactions. 2nd edition. CRC Press; 2009.
25.
26.
go back to reference Oswald-Richter KA, Beachboard DC, Seeley EH, Abraham S, Shepherd BE, Jenkins CA, Culver DA, Caprioli RM, Drake WP. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32:1129–40.CrossRef Oswald-Richter KA, Beachboard DC, Seeley EH, Abraham S, Shepherd BE, Jenkins CA, Culver DA, Caprioli RM, Drake WP. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32:1129–40.CrossRef
27.
go back to reference Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, Grunewald J, Moller DR. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol. 2008;181:8784–96.CrossRef Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, Grunewald J, Moller DR. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol. 2008;181:8784–96.CrossRef
28.
go back to reference Schupp JC, Tchaptchet S, Lützen N, Engelhard P, Müller-Quernheim J, Freudenberg MA, Prasse A. Immune response to Propionibacterium acnes in patients with sarcoidosis—in vivo and in vitro. BMC Pulm Med. 2015;15:75.CrossRef Schupp JC, Tchaptchet S, Lützen N, Engelhard P, Müller-Quernheim J, Freudenberg MA, Prasse A. Immune response to Propionibacterium acnes in patients with sarcoidosis—in vivo and in vitro. BMC Pulm Med. 2015;15:75.CrossRef
29.
go back to reference Beijer E, Kraaijvanger R, Roodenburg C, Grutters JC, Meek B, Veltkamp M. Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype. Clin Exp Immunol. 2021;203:115–24.CrossRef Beijer E, Kraaijvanger R, Roodenburg C, Grutters JC, Meek B, Veltkamp M. Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype. Clin Exp Immunol. 2021;203:115–24.CrossRef
30.
go back to reference Beijer E, Seldenrijk K, Eishi Y, Uchida K, Damen J, Grutters JC, Veltkamp M. Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients. ERJ Open Res. 2020. Beijer E, Seldenrijk K, Eishi Y, Uchida K, Damen J, Grutters JC, Veltkamp M. Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients. ERJ Open Res. 2020.
31.
go back to reference Laney AS, Cragin LA, Blevins LZ, Sumner AD, Cox-Ganser JM, Kreiss K, Moffatt SG, Lohff CJ. Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air. 2009;19:83–90.CrossRef Laney AS, Cragin LA, Blevins LZ, Sumner AD, Cox-Ganser JM, Kreiss K, Moffatt SG, Lohff CJ. Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air. 2009;19:83–90.CrossRef
32.
go back to reference Valeyre D, Soler P, Clerici C, Pré J, Battesti JP, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43:516–24.CrossRef Valeyre D, Soler P, Clerici C, Pré J, Battesti JP, Georges R, Hance AJ. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43:516–24.CrossRef
33.
go back to reference Janot AC, Huscher D, Walker M, Grewal HK, Yu M, Lammi MR, Saketkoo LA. Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:138–43.PubMed Janot AC, Huscher D, Walker M, Grewal HK, Yu M, Lammi MR, Saketkoo LA. Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:138–43.PubMed
34.
go back to reference Xin S, Ye L, Man G, Lv C, Elias PM, Man M-Q. Heavy cigarette smokers in a Chinese population display a compromised permeability barrier. BioMed Res Int. 2016; 9704598. Xin S, Ye L, Man G, Lv C, Elias PM, Man M-Q. Heavy cigarette smokers in a Chinese population display a compromised permeability barrier. BioMed Res Int. 2016; 9704598.
35.
go back to reference Scadding JG. Mycobacterium tuberculosis in the aetiology of sarcoidosis. Br Med J. 1960;2:1617–23.CrossRef Scadding JG. Mycobacterium tuberculosis in the aetiology of sarcoidosis. Br Med J. 1960;2:1617–23.CrossRef
36.
go back to reference De Sadeleer LJ, Meert C, Yserbyt J, Slabbynck H, Verschakelen JA, Verbeken EK, Weynand B, De Langhe E, Lenaerts JL, Nemery B, Van Raemdonck D, Verleden GM, Wells AU, Wuyts WA. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases. Chest. 2018;153:1416–23.CrossRef De Sadeleer LJ, Meert C, Yserbyt J, Slabbynck H, Verschakelen JA, Verbeken EK, Weynand B, De Langhe E, Lenaerts JL, Nemery B, Van Raemdonck D, Verleden GM, Wells AU, Wuyts WA. Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases. Chest. 2018;153:1416–23.CrossRef
37.
go back to reference Solà R, Boj M, Hernandez-Flix S, Camprubí M. Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet. 2009;373:1943–4.CrossRef Solà R, Boj M, Hernandez-Flix S, Camprubí M. Silica in oral drugs as a possible sarcoidosis-inducing antigen. Lancet. 2009;373:1943–4.CrossRef
38.
go back to reference Ronsmans S, Verbeken EK, Adams E, Keirsbilck S, Yserbyt J, Wuyts WA, Swennen R, Hoet PH, Nemery B. Granulomatous lung disease in two workers making light bulbs. Am J Ind Med. 2019;62:908–13.CrossRef Ronsmans S, Verbeken EK, Adams E, Keirsbilck S, Yserbyt J, Wuyts WA, Swennen R, Hoet PH, Nemery B. Granulomatous lung disease in two workers making light bulbs. Am J Ind Med. 2019;62:908–13.CrossRef
39.
go back to reference Gysbrechts C, Michiels E, Verbeken E, Verschakelen J, Dinsdale D, Nemery B, Demedts M. Interstitial lung disease more than 40 years after a 5 year occupational exposure to talc. Eur Respir J. 1998;11:1412–5.CrossRef Gysbrechts C, Michiels E, Verbeken E, Verschakelen J, Dinsdale D, Nemery B, Demedts M. Interstitial lung disease more than 40 years after a 5 year occupational exposure to talc. Eur Respir J. 1998;11:1412–5.CrossRef
40.
go back to reference Webber MP, Yip J, Zeig-Owens R, Moir W, Ungprasert P, Crowson CS, Hall CB, Jaber N, Weiden MD, Matteson EL, Prezant DJ. Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers. Respir Med. 2017;132:232–7.CrossRef Webber MP, Yip J, Zeig-Owens R, Moir W, Ungprasert P, Crowson CS, Hall CB, Jaber N, Weiden MD, Matteson EL, Prezant DJ. Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers. Respir Med. 2017;132:232–7.CrossRef
41.
go back to reference Graff P, Larsson J, Bryngelsson I-L, Wiebert P, Vihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case–control study. BMJ Open Br Med J Publ Group. 2020;10:038926. Graff P, Larsson J, Bryngelsson I-L, Wiebert P, Vihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case–control study. BMJ Open Br Med J Publ Group. 2020;10:038926.
42.
go back to reference Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLENNAN G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164: 1885–1889. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLENNAN G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R, A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164: 1885–1889.
Metadata
Title
Associations between occupational and environmental exposures and organ involvement in sarcoidosis: a retrospective case-case analysis
Authors
Steven Ronsmans
Jolien De Ridder
Eline Vandebroek
Stephan Keirsbilck
Benoit Nemery
Peter H. M. Hoet
Steven Vanderschueren
Wim A. Wuyts
Jonas Yserbyt
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2021
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-021-01818-5

Other articles of this Issue 1/2021

Respiratory Research 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine